Iopromide

CAS No. 73334-07-3

Iopromide( Ultravist )

Catalog No. M15809 CAS No. 73334-07-3

Iopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist which is produced by Bayer Healthcare.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 39 In Stock
10MG 55 In Stock
25MG 87 In Stock
50MG 129 In Stock
100MG 177 In Stock
200MG 266 In Stock
500MG 441 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Iopromide
  • Note
    Research use only, not for human use.
  • Brief Description
    Iopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist which is produced by Bayer Healthcare.
  • Description
    Iopromide is a molecule used as a contrast medium. It is marketed under the name Ultravist which is produced by Bayer Healthcare. It is a low osmolar, non-ionic contrast agent for intravascular use.(In Vivo):Contrast medium-induced nephropathy can be induced by tail intravenous administration of iopromide. In randomized controlled trials, the global image quality and diagnostic quality with iobitridol does not differ from those with other low-osmolar contrast media (iohexol, iopromide, iopamidol, iomeprol and ioxaglate) or the iso-osmolar contrast medium iodixanol in adults or children undergoing radiographic imaging. Large post-marketing surveillance studies have confirmed that iobitridol produces good or excellent opacification and is an effective contrast agent in the vast majority of patients. Iobitridol is generally well tolerated and had a tolerability profile similar to that of other low-osmolar and iso-osmolar contrast media. Thus, iobitridol is an effective intravascular agent for contrast enhancement in diagnostic imaging.
  • In Vitro
    ——
  • In Vivo
    Contrast medium-induced nephropathy can be induced by tail intravenous administration of iopromide. In randomized controlled trials, the global image quality and diagnostic quality with iobitridol does not differ from those with other low-osmolar contrast media (iohexol, iopromide, iopamidol, iomeprol and ioxaglate) or the iso-osmolar contrast medium iodixanol in adults or children undergoing radiographic imaging. Large post-marketing surveillance studies have confirmed that iobitridol produces good or excellent opacification and is an effective contrast agent in the vast majority of patients. Iobitridol is generally well tolerated and had a tolerability profile similar to that of other low-osmolar and iso-osmolar contrast media. Thus, iobitridol is an effective intravascular agent for contrast enhancement in diagnostic imaging.
  • Synonyms
    Ultravist
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    73334-07-3
  • Formula Weight
    791.12
  • Molecular Formula
    C18H24I3N3O8
  • Purity
    >98% (HPLC)
  • Solubility
    Soluble in DMSO
  • SMILES
    c1(c(c(c(I)c(c1I)NC(COC)=O)C(NC[C@@H](CO)O)=O)I)C(N(C[C@@H](CO)O)C)=O
  • Chemical Name
    1,3-Benzenedicarboxamide, N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-5-((methoxyacetyl)amino)-N-methyl-

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Palkowitsch PK, et al. Acta Radiol. 2014 Jul;55(6):707-14.
molnova catalog
related products
  • 16,25-Diacetate cycl...

    Reference standard.

  • (±)-Lisofylline

    (±)-Lisofylline is an enantiomer-specific, alkyl-substituted methylxanthine, which has specific and potent activity in down-regulating leukocyte activation. (±)-Lisofylline is an anti-inflammatory agent.

  • Trimethoxystilbene

    3, 5, 4'-Trimethoxystilbene, a natural methoxylated analog of resveratrol, inhibits breast Y cell invasiveness by downregulation of PI3K/Akt and Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.